José Ángel Fontenla Gil-rekin lankidetzan egindako argitalpenak (5)

2020

  1. Novel coumarin-pyridazine hybrids as selective MAO-B inhibitors for the Parkinson's disease therapy

    Bioorganic Chemistry, Vol. 104

1993

  1. Cyproheptadine analogues: Synthesis, antiserotoninergic activity, and structure‐activity relationships

    Journal of Pharmaceutical Sciences, Vol. 82, Núm. 11, pp. 1090-1093

  2. Pyridazine derivatives. XI: Antihypertensive activity of 3‐hydrazinocycloheptyl[1,2‐c]pyridazine and its hydrazone derivatives

    Journal of Pharmaceutical Sciences, Vol. 82, Núm. 3, pp. 286-290

1989

  1. Pyridazine Derivatives, VII. Synthesis and Hypotensive Activity of 3‐Hydrazinocycloalkyl[1,2‐c]pyridazines and their Derivatives

    Archiv der Pharmazie, Vol. 322, Núm. 6, pp. 331-336

1988

  1. Pyridazine Derivatives, VI. Synthesis and Hypotensive Activity of 3‐Hydrazinethieno(2,3‐h)Cinnoline and its Derivatives

    Archiv der Pharmazie, Vol. 321, Núm. 10, pp. 735-738